Raymond James & Associates’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-13,008
| Closed | -$36K | – | 3515 |
|
|
2017
Q4 | $36K | Buy |
13,008
+1,341
| +11% | +$3.71K | ﹤0.01% | 3236 |
|
|
2017
Q3 | $40K | Buy |
+11,667
| New | +$40K | ﹤0.01% | 3196 |
|
|
2014
Q1 | – | Sell |
-53,001
| Closed | -$447K | – | 2181 |
|
|
2013
Q4 | $447K | Sell |
53,001
-7,359
| -12% | -$62.1K | ﹤0.01% | 1711 |
|
|
2013
Q3 | $481K | Buy |
60,360
+22,295
| +59% | +$178K | ﹤0.01% | 1617 |
|
|
2013
Q2 | $294K | Buy |
+38,065
| New | +$294K | ﹤0.01% | 1708 |
|